Lupin Gets Tentative Approval From FDA for Combination AIDS Drug

Lupin Ltd. (LPC), the world’s largest maker of anti-tuberculosis medicines, received tentative approval from the U.S. Food and Drug Administration for its combination AIDS drug containing lamivudine and zidovudine, according to a statement on the regulator’s website.

To contact the reporter on this story: Adi Narayan in Mumbai at

To contact the editor responsible for this story: Niveditha Ravi at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.